Welcome

Welcome to the Cochrane Dementia and Cognitive Improvement Group, part of Cochrane’s Mental Health and Neuroscience Network.

Our aim is to provide the highest quality evidence about the care and medical treatment of people with dementia, delirium and other cognitive disorders, and about the diagnosis and prevention of these disorders. We do this by producing systematic reviews addressing questions which are important to patients, their families, and healthcare professionals from all disciplines. You can read more about our scope and our work here.

We welcome contact from anyone who would like to help us to identify important questions, produce or publicise our reviews, or just generally comment on our work.

July 2021 News

Survey in collaboration with the European Geriatric Medicine Society

In July 2021 we undertook a survey in collaboration with the European Geriatric Medicine Society to gauge opinions on priorities for CDCIG reviews. We created an electronic questionnaire and circulated to attendees of an online webinar by CDCIG and the Dementia and Systematic Review & Meta-analysis SIGs of EuGMS. The survey asked about: the usefulness and priority of updating existing reviews; the usefulness in the respondent's practice and priority of topic areas; and prioritising different types of research.

The existing review "Cholinesterase inhibitors for dementia due to Alzheimer's disease: overview and network meta-analysis" scored highest for both usefulness and priority for updating, and the review "Music-based therapeutic interventions for people with dementia" scored lowest for both usefulness and priority for updating.

The topic area of "Post-diagnostic care and support for people with dementia in the community" scored highest for usefulness, and the topic area of "Interventions intended specifically to support family caregivers" scored highest for priority for updating. The 2 reviews with the lowest priority for updating were "Service organisation and/or training of health and social care staff" and "Complementary or arts therapies for dementia-related symptoms".

In the section on different types of research those with the highest score for both importance and which CDCIG should focus on were "Studies of factors that predict outcomes (prognostic research)" and "Comparisons of several different interventions (network meta-analysis)". The type of research with the lowest importance was "Studies of opinions or experiences (qualitative research)".

The respondents were physicians specialising in geriatric medicine and held the role of hospital clinicians, academics and community clinicians. Respondents were from Belgium, Bulgaria, Chile, England, France, Germany, Hungary, Ireland, Netherlands, Scotland, Spain, Turkey, UK and USA.